Clinical trials: Inflammatory Bowel Diseases (IBD)
Ulcerative Colitis
Diet Treatment of Patients With Ulcerative Colitis in Remission
The study examines the effect of a low FODMAP diet in patients with UC in remission but still having GI symptoms (IBS in IBD). 15 patients will be on watchful waiting. 15 patients will be on low FODMAP diet.
- Trial name
- NCT02469220
- Testing
- Low FODMAP, Standardized FODMAP
- Where
- Denmark
- Volunteers
- 19 people
- Sponsor
- Regionshospital Nordjylland
Inflammatory Bowel Disease (IBD), Crohn's Disease
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
The primary reason of this study is to observe current treatment options in participants receiving Vedolizumab, intravenous (IV) or subcutaneous (SC), for IBD in Poland.
- Conditions
- Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis
- Trial name
- VARIETY (NCT05384080)
- Where
- 11 sites in Poland
- Volunteers
- 165 people
- Sponsor
- Takeda
Crohn Disease (CD), Dynamic Prediction Model
Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort Study
This single-center retrospective cohort study aims to develop and internally validate a dynamic prediction model that uses longitudinal data from routinely collected blood tests to continuously assess the risk of Crohn's disease…
- Trial name
- NCT07644390
- Volunteers
- 500 people
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
Crohn's Disease
Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's Disease
This retrospective observational study aims to develop an artificial intelligence-based system for the precise classification and prognostic prediction of small bowel Crohn's disease.
- Trial name
- NCT07757217
- Testing
- Artificial Intelligence-Based Multimodal Analysis
- Where
- China
- Volunteers
- 437 people
- Sponsor
- Shanghai 10th People's Hospital
Ulcerative Colitis
Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis
The purpose of this study is to determine whether fecal calprotectin, fecal immunochemical test, and Rome III criteria for irritable bowel syndrome (IBS) can predict mucosal healing in patients with quiescent ulcerative colitis…
- Trial name
- PINQLE (NCT02640391)
- Testing
- colonoscopy
- Where
- South Korea
- Volunteers
- 127 people
- Sponsor
- Kyungpook National University Hospital
Healthy Adult Volunteers, Active Ulcerative Colitis
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
This Phase 1b/2a clinical development plan is focused on the use of NP-201 acetate injection to investigate the pharmacokinetics (PK), safety, efficacy, PD (pharmacodynamic) markers (Phase 1b) and tolerability of NP-201 acetate…
- Conditions
- Healthy Adult Volunteers, Active Ulcerative Colitis, Active Ulcerative Colitis (UC)
- Trial name
- NCT06681389
- Testing
- NP-201 acetate injection (Part A)
- Where
- Australia
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- NIBEC Co., Ltd.
IBD, Ulcerative Colitis
Ibd CAncer and seRious Infections in France (I-CARE 2)
This is a French prospective longitudinal observational multicentre cohort study. Primary objective : to assess prospectively the presence and the extent of safety concerns (cancer, serious infections, arterial and venous…
- Conditions
- IBD, Ulcerative Colitis, Crohn Disease
- Trial name
- I-CARE 2 (NCT06089590)
- Testing
- Non-interventional
- Where
- 2 sites in France
- Volunteers
- 6,000 people
- Sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Ulcerative Colitis
Prediction Model for Response to Biologics and Small Molecular Agent for UC
This prospective observational study is going to develop and validate a prediction model of response to biologic agents and small molecular agents for Korean patients with ulcerative colitis.
- Trial name
- NCT05186623
- Testing
- Vedolizumab, Ustekinumab, or Tofacitinib
- Where
- South Korea
- Volunteers
- 300 people
- Sponsor
- Asan Medical Center
Sleep Disorder, Inflammatory Bowel Diseases
Sleep Disorder in Inflammatory Bowel Disease and Its Association With Disease Activity
Recently, an association between active inflammatory bowel disease (IBD) and poor sleep quality has been proposed; however, the causal relationship has not yet been established.
- Trial name
- NCT05536817
- Where
- Thailand
- Volunteers
- 100 people
- Sponsor
- Mahidol University
Crohn's Disease
Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease
The study will examine the safety and effectiveness of brodalumab for the treatment of moderate to severe Crohn's disease. Participants will randomly assigned to receive either brodalumab or placebo (a lookalike liquid that…
- Trial name
- NCT01150890
- Testing
- Brodalumab
- Where
- 50 sites in United States, Australia and 6 more
- Volunteers
- 130 people
- Sponsor
- Amgen
Crohn Disease
Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid
In the clinical trial the investigators will assess efficacy, safety and tolerability after single and multiple doses of 3 millimolar 5 aminolevulinic acid (Gliolan®) in combination with blue-light (405 nanometer) photopheresis…
- Trial name
- NCT04164849
- Testing
- 5-aminolevulinic acid, Blue light photopheresis, Transfusion
- Where
- Norway
- Volunteers
- 7 people
- Sponsor
- University Hospital, Akershus
Ulcerative Colitis
Thermography in Surveillance of Ulcerative Colitis
Ulcerative colitis represents a chronic condition occurring in relapsing and remitting fashion with uncertain outcome and requires lifelong treatment with considerable side effects.
- Trial name
- Thermo (NCT02149043)
- Testing
- Thermography, Colonoscopy
- Where
- Croatia
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- University Hospital Dubrava
Colitis, Ulcerative
BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
This trial has two sequentially enrolling parts with different objectives. The primary objectives of this trial are to prove the concept of clinical activity of BI655130 (SPESOLIMAB) in patients with moderate-to-severely active…
- Trial name
- NCT03482635
- Testing
- Spesolimab
- Where
- 54 sites in United States, Austria and 10 more
- Volunteers
- 98 people
- Sponsor
- Boehringer Ingelheim
Inflammatory Bowel Diseases, Ulcerative Colitis
Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD)
This is a randomized, double-blind placebo controlled study to assess for safety, tolerability and nutritional impact of oral serum bovine immunoglobulin (SBI) on pediatric patients and young adults with inflammatory bowel…
- Conditions
- Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
- Trial name
- NCT04223518
- Testing
- Serum bovine immunoglobulin
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Monisha Hitesh Shah
Ulcerative Colitis, Crohn's Disease
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
This study will evaluate the long-term safety and tolerability of UTTR1147A in participants with moderate to severe ulcerative colitis (UC) or Crohn's disease (CD), enrolling up to 320 participants from the parent studies: Phase…
- Trial name
- NCT03650413
- Testing
- UTTR1147A
- Where
- 57 sites in United States, Bulgaria and 12 more
- Volunteers
- 143 people
- Sponsor
- Genentech, Inc.
Crohn Disease, Ulcerative Colitis
Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC) are chronic inflammatory bowel diseases (IBD). Adalimumab is a human monoclonal antibody against TNF-alpha, a pro-inflammatory cytokine that mediates the inflammatory response in…
- Trial name
- GUIDE (NCT06117423)
- Testing
- Adalimumab-680LT, Control
- Where
- Netherlands
- Volunteers
- 21 people
- Sponsor
- University Medical Center Groningen
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
Baby Detect : Genomic Newborn Screening
Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions.
- Conditions
- Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1, Phosphoglucomutase 1 Deficiency, Maturity Onset Diabetes of the Young
- Trial name
- BabyDetect (NCT05687474)
- Where
- Belgium
- Volunteers
- 6,824 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire de Liege
Inflammatory Bowel Diseases
Mesotherapy Treatment of Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a gastrointestinal transit disorder characterized by chronic abdominal pain and impaired transit in the absence of demonstrated organic disease.
- Trial name
- MESOCOLO (NCT06261320)
- Testing
- Mesotherapy with mesocaine, thiocolchicoside, amitriptyline, magnesium pidolate
- Where
- France
- Volunteers
- 27 people
- Sponsor
- Polyclinique de l'Europe
Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC)
Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
This clinical trial tests if oral vancomycin can safely treat active ulcerative colitis (UC) in adults who also have primary sclerosing cholangitis (PSC), a liver condition.
- Trial name
- DRIVE-UP (NCT07341282)
- Testing
- Vancomycin (blinded), Vancomycin (open-label extension)
- Where
- Canada
- Volunteers
- 14 people
- Sponsor
- McMaster University
Ulcerative Colitis
An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
Ulcerative colitis (UC) is an idiopathic, chronic, inflammatory disease affecting the colon. Participants with UC have mucosal inflammation starting in the rectum that can extend continuously to proximal segments of the colon.
- Trial name
- PROFUNDUS (NCT05494606)
- Where
- 153 sites in Argentina, Australia and 15 more
- Volunteers
- 785 people
- Sponsor
- AbbVie
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.